Marinus Pharmaceuticals Inc Forecast, price target & analysts
Marinus Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation
Marinus Pharmaceuticals Inc Classifications & Recommendation:
Marinus Pharmaceuticals Inc Price Target
| Target Price | $1.50 |
| Price | $0.55 |
| Potential |
172.73%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Marinus Pharmaceuticals Inc 2026 .
The average Marinus Pharmaceuticals Inc target price is $1.50.
This is
172.73%
register free of charge
$2.00
263.64%
register free of charge
$1.00
81.82%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend Marinus Pharmaceuticals Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Marinus Pharmaceuticals Inc stock has an average upside potential 2026 of
172.73%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 30.99 | 35.87 |
| 21.62% | 15.74% | |
| Net Margin | -468.38% | -307.74% |
| 324.00% | 34.30% |
2 Analysts have issued a sales forecast Marinus Pharmaceuticals Inc 2024 . The average Marinus Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
2 Marinus Pharmaceuticals Inc Analysts have issued a net profit forecast 2024. The average Marinus Pharmaceuticals Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.63 | -2.00 |
| 415.69% | 23.95% | |
| P/E | negative | |
| EV/Sales | 2.30 |
2 Analysts have issued a Marinus Pharmaceuticals Inc forecast for earnings per share. The average Marinus Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Marinus Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Marinus Pharmaceuticals Inc...
Current Marinus Pharmaceuticals Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald | Locked ➜ Locked | Locked | Nov 14 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 14 2024 |
| D. Boral Capital | Locked ➜ Locked | Locked | Nov 13 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Oct 25 2024 |
| TD Cowen | Locked ➜ Locked | Locked | Oct 25 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Oct 25 2024 |
| Cantor Fitzgerald | Locked ➜ Locked | Locked | Oct 25 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Oct 25 2024 |
|
Locked
TD Cowen: Locked ➜ Locked
|
Oct 25 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Oct 25 2024 |
|
Locked
Cantor Fitzgerald: Locked ➜ Locked
|
Oct 25 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
